Back To Schedule
Wednesday, June 22 • 9:00am - 10:00am
#302: Mission-Driven Research Partners: How Patient Advocacy Organizations Can Help Advance Your Therapeutic R&D Programs

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Basic
CE: ACPE 1.00 Application UAN: 0286-0000-22-594-L04-P ; CME 1.00; RN 1.00

Similar to CROs, many patient advocacy organizations (PAOs) provide services to advance therapeutic R&D programs in alignment with their missions. Case studies of successful PAO engagements and best practices for these partnerships will be discussed. Join the DIA Patient Engagement Community for a follow up round table discussion (session #355 RT) on Wednesday, June 22, 3:00pm - 4:00pm.

Learning Objectives

Identify patient advocacy organizations (PAOs) with high-quality resources and expertise to contribute to the success of your therapeutic development program; Compare the process of working with PAOs to working with traditional CROs and academic partners; Create efficiencies in your pipeline by building positive relationships with PAOs early and throughout the development of your programs.


Hollie Schmidt, MS


Patient Perspective
Danielle Kerkovich, PhD

Industry Perspective
Melissa Dupont

Patient Perspective
Richard Mohs, PhD

avatar for Melissa Dupont

Melissa Dupont

R&D Patient Engagement Lead, Sanofi, United States
Melissa's role is part of the Patient Informed Development and Health Value Translation Team, she is overseeing primarily the Neurology portfolio. This role is the face of Sanofi R&D to external Patient Advocacy organizations. A major responsibility of this role is to drive the patient... Read More →

Danielle Kerkovich

Director of Research Development and Partnerships, International Fibrodyslasia Ossificans Association (IFOPA), United States
Ask Danielle about nonprofit medical research foundation strategies and you'll get a lively discussion of how building a well-informed, multifaceted strategy is the difference between expensive hope and real progress. In my role with the International Fibrodysplasia Ossificans Progressiva... Read More →
avatar for Richard Mohs

Richard Mohs

Chief Scientific Officer, Global Alzheimer’s Platform Foundation, United States
Richard C. Mohs is the Chief Science Officer for the Global Alzheimer’s Platform (GAP) Foundation, a patient-centered, non-profit organization enhancing the speed and quality of clinical trials for Alzheimer’s disease. He retired in 2015 from Eli Lilly and Company where he held... Read More →
avatar for Hollie Schmidt

Hollie Schmidt

Vice President of Scientific Operations, Accelerated Cure Project, United States
Hollie Schmidt is the VP of Scientific Operations at the Accelerated Cure Project, a research-focused patient advocacy organization for MS. She has planned, developed, and directed numerous initiatives aimed at creating research resources and bridging different stakeholder communities... Read More →

Wednesday June 22, 2022 9:00am - 10:00am CDT
Room 176 McCormick Place 2301 South Indiana Avenue Gate 40 Chicago, IL 60616
  02: ClinTrials -ClinOps, Forum |   05: Patient Engagement, Forum